MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES: $111M Department of Health and Human Services Grant
Summary
The Michigan Department of Health and Human Services received a $111M grant from SAMHSA for opioid response, focusing on prevention, treatment, and recovery. As a state-level award, no publicly traded companies directly benefit, but the contract signals continued federal investment in opioid abatement, supporting healthcare service providers and pharmaceutical manufacturers indirectly.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No publicly traded entity is directly funded by this $111M state grant.
- 2.The opioid treatment sector continues to receive substantial federal support, benefiting generic drug makers and treatment service providers.
- 3.Investors should monitor SAMHSA's SOR grant announcements for sector-wide demand signals but avoid over-attribution to specific companies.
Market Implications
The contract is a routine renewal of state-level opioid funding and does not create a material event for any single public company. The broader trend of sustained federal opioid spending (over $1B annually) provides a steady tailwind for pharmaceutical firms specializing in addiction treatments and naloxone distribution. However, without a direct tie to a specific ticker, the market impact is negligible for equity traders.
Full Analysis
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the Michigan Department of Health and Human Services a $111M project grant under the State Opioid Response (SOR) initiative. The award runs from September 2024 to September 2027 and targets adults aged 25-44 with opioid use disorder, along with specific populations such as African Americans, adolescents, and American Indians/Alaska Natives. The program aims to expand access to naloxone, medication-assisted treatment (MOUD), harm reduction services, and recovery support. Since the recipient is a state government entity rather than a publicly traded company, no direct stock market impact is attributable. However, this contract is part of a broader federal push (over $1.5B annually in SOR grants) that benefits the entire opioid treatment ecosystem, including pharmaceutical firms producing buprenorphine, naloxone, and naltrexone, as well as behavioral health service providers. The related bills in the HillSignal database (e.g., S5006, S5116) are tangentially healthcare-related but lack specific provisions for opioid funding. Historically, similar SOR grants have sustained demand for addiction treatment services and medications, though the impact on individual public companies remains diffuse. Supply chain beneficiaries include manufacturers of naloxone (e.g., Amphastar, Emergent BioSolutions) and buprenorphine (Indivior, Dr. Reddy's), but no specific contract-level revenue attribution is possible. The contract's multi-year nature provides stable funding for Michigan's opioid response infrastructure.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.6B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.4B Department of Homeland Security Grant
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Contract Details
Recipient
MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES
Award Amount
$110,940,860
Awarding Agency
Department of Health and Human Services
Sub-Agency
Substance Abuse and Mental Health Services Administration
Contract Type
PROJECT GRANT (B)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →